Navigation Links
Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
Date:4/7/2009

will be available immediately by prescription at retail pharmacies nationwide.

In addition to RAPAFLO(TM), Watson will soon launch GELNIQUE, the first and only topical gel for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Watson also has submitted a New Drug Application for a 6-month formulation of Trelstar(R) (triptorelin pamoate), a luteinizing hormone releasing hormone (LHRH) agonist for the palliative treatment of advanced prostate cancer. Watson anticipates that FDA will take action on this application in the third quarter 2009.

About RAPAFLO

RAPAFLO(TM) is an effective, selective alpha-1 adrenergic receptor antagonist that binds with high affinity to the alpha 1a receptors concentrated in the prostate, bladder base and neck and seminal vesicles. It regulates the receptors, causing smooth muscles in these tissues to relax, resulting in improved urine flow and a reduction in BPH symptoms. The binding affinity for the alpha 1B receptors that regulate smooth muscle relaxation and blood pressure effects is lower, minimizing the potential for side effects.

In two Phase 3 studies, 8 mg once-daily RAPAFLO(TM) taken for 12 weeks resulted in significant and rapid relief of BPH symptoms compared with placebo, as measured by the International Prostate Symptom Score (IPSS). IPSS includes irritative (frequency, urgency, and nocturia), and obstructive (hesitancy, incomplete emptying, intermittency, and weak stream) symptoms. RAPAFLO also has been proven to significantly improve Qmax scores (maximum urine flow rates) as early as two hours following first dose and at 12 weeks of treatment.

In clinical trials, RAPAFLO(TM) also demonstrated minimal electro cardiac effects on the cardiovascular system, without any meaningful prolongation of the QT interval. The most common drug-related side effect was retrograde ejaculation
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
2. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
3. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
4. Watson Launches Generic Biaxin(R) XL
5. Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder
6. Cynosure Announces Presentation of Favorable Results from Post-Marketing Studies of Smartlipo MPX
7. Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis
8. Schering-Plough Announces Results of the Early ACS Trial
9. Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders
10. Lilly Announces Inconclusive Phase II Study Results for mGlu2/3 at the International Congress on Schizophrenia Research
11. Impulse Dynamics Announces Pivotal Results at the American College of Cardiology Annual Meeting Late-Breaking Session
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... HILL, N.C. , June 18, 2013  Recent ... more difficult for Medical Education groups at large pharmaceutical ... on the safe and effective use of their new ... the pharma industry, it is crucial that these ... reaching healthcare professionals. To address the changes ...
(Date:6/18/2013)... , June 18, 2013  Women are frequently ... but unfortunately they often do not give the same ... have kept information from their doctor because they were ... according to a recent survey conducted by Allergan and ... dedicated to bringing education, funding and research to the ...
(Date:6/18/2013)... The board of directors of Eli Lilly ... a dividend for the third quarter of 2013 of ... The dividend is payable September 10, 2013 to ... August 15, 2013. Lilly, a leading innovation-driven ... by applying the latest research from its own worldwide ...
Breaking Medicine Technology:Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints 2New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 2New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 3New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 4New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 5New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 6New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 7New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 8New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 9
... RATE- MEDIAN SURVIVAL OF 10.5 MONTHS IN COMPLETE ... MEETINGSOUTH SAN FRANCISCO, Calif., March 3 Hana ... new positive preliminary efficacy results from a planned ... trial evaluating Marqibo(R) (vincristine sulfate liposomes injection) for ...
... Society of Gynecologic Oncologists (SGO) and the American College ... breast disease fellowship training program for gynecologic oncologists. ... program provides support for a gynecologic oncologist to complete ... of breast cancer and related disease. "As experts ...
Cached Medicine Technology:Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia 2Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia 3Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia 4Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia 5SGO and ACOG Announce Breast Cancer Fellowship Program for Gynecologic Oncologists 2SGO and ACOG Announce Breast Cancer Fellowship Program for Gynecologic Oncologists 3
(Date:6/19/2013)... MinuteHound, a leading time and attendance technology ... up to 8% on payroll costs. MinuteHound’s system eliminates ... systems. Their biometric system is simple: Employees place their ... in and out automatically. Employee time clocks ... punching. , Because the fingerprint data is encrypted ...
(Date:6/19/2013)... Faith4Kidz is starting a new fundraising effrt to support ... help showing support for kids to learn how to independently ... out the website, http://www.gracenfaith.com to see Faith4Kidz logo ... and blue stars as a symbol of our country and ... as the stars we should encourage our children to reach ...
(Date:6/18/2013)... 2013 As a sponsor of the 2013 Fourth of ... at Lake Meridian Chiropractic want you to get out and celebrate! ... the event and are excited to be involved. “My husband and ... always loved going to the Kent Splash event. It's a tradition ... sense to financially support this fun day.” , The ...
(Date:6/18/2013)... York (PRWEB) June 19, 2013 Parker ... the rights of victims injured by dangerous drugs and ... an Arizona woman who alleges that she was ... filed on May 30th in the U.S. District Court ... No. 2:13-cv-12677) in the multidistrict litigation entitled In Re: ...
(Date:6/18/2013)... Daily Gossip Magazine has always kept its readers entertained ... , The magazine has decided to prepare readers for the ... recipe every week . , According to Daily Gossip ... readers who are looking to get insights into this type ... anabolic food is almost entirely based on healthy, yet tasteful ...
Breaking Medicine News(10 mins):Health News:MinuteHound Announces How Cloud Computing Technology Boosts Savings 2Health News:MinuteHound Announces How Cloud Computing Technology Boosts Savings 3Health News:Faith4Kidz Introduces Patriotic Hats to Benefit the "Grace in Faith Equals Peace" Mission 2Health News:Lake Meridian Chiropractic of Kent, WA to Sponsor the Fireworks Finale at 15th Annual Fourth of July Splash 2Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 2Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 3Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 4Health News:Anabolic Cooking Book Review Exposes Dave Ruel’s Top 10 ‘Anabolicious’ Recipes for BodyBuilders 2
... Says NCPA Study, DALLAS, Sept. 27 The ... so rapidly that these benefits,are now the fastest rising ... the rate of retirement benefits, according to a new,analysis ... a separate,study also released today, the NCPA says Chile,s ...
... gene variants that convey risk for schizophrenia affect apparently healthy ... may have different versions of these genes, called alleles. ... end up with schizophrenia, this does not mean they are ... the largest study of its kind to date, scheduled for ...
... Paramount Acquisition,Corp. (OTC Bulletin Board: PMQC, PMQCU, ... the filing of a third,amendment to the preliminary ... that was originally filed on June 18, 2007. ... meeting of,stockholders to be held to consider the ...
... Calif., Sept. 27 With cold and flu,season ... infants and toddlers,will soon be visiting their family ... most cases, children suffering from ear infections,are prescribed ... infection,but when antibiotics fail to stop ear infections ...
... to women worried about whether getting pregnant after cancer ... by Norwegian scientists, presented today (Thursday) at the European ... almost all types of cancer, the survival of women ... after being treated for the disease is no different ...
... NEWBERG, Ore., Sept. 27 A team of internationally,recognized ... spa,that will open in the spring of 2009 along ... northeast Newberg. Joan Austin, president of Springbrook Properties, ... Beach, Fla., will oversee,development of what is destined to ...
Cached Medicine News:Health News:Disability System Sorely in Need of Reform 2Health News:Disability System Sorely in Need of Reform 3Health News:Schizophrenia candidate genes affect even healthy individuals 2Health News:Paramount Acquisition Corp. Files Amendment to Preliminary Proxy Statement for Proposed Acquisition of Chem Rx 2Health News:Paramount Acquisition Corp. Files Amendment to Preliminary Proxy Statement for Proposed Acquisition of Chem Rx 3Health News:Paramount Acquisition Corp. Files Amendment to Preliminary Proxy Statement for Proposed Acquisition of Chem Rx 4Health News:Antibiotics Not Always Best Bet for Battling Childhood Ear Infections 2Health News:Study indicates pregnancy does not harm chances of survival from cancer 2Health News:International Consulting Firm Health Fitness Dynamics Hired to Oversee Springbrook Inn's Planned New Spa 2Health News:International Consulting Firm Health Fitness Dynamics Hired to Oversee Springbrook Inn's Planned New Spa 3
Tendril DX active-fixation leads allows for lower thresholds initially and during the lead maturation phase....
... Guidant Flextend lead is ... lead with an extendable/retractable ... helix design offers various ... permanent implantation in the ...
... PY series leads are implantable bipolar ... stimulation of either the atrium or ... screw can be extended or retracted ... lead tip contains an anti-chattering mechanism ...
Used with permanent pacing leads....
Medicine Products: